|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6171 USD | -8.65% |
|
+19.83% | -24.84% |
Novo Integrated Sciences, Inc. reported earnings results for the full year ended August 31, 2023. For the full year, the company reported sales was USD 12.57 million compared to USD 11.74 million a year ago. Net loss was USD 13.21 million compared to USD 32.85 million a year ago.
Basic loss per share from continuing operations was USD 1.3 compared to USD 11.28 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.84% | 11.76M | |
| -14.25% | 85.35B | |
| +14.46% | 81.95B | |
| +9.37% | 28.99B | |
| -11.40% | 16.98B | |
| -0.36% | 16.85B | |
| +0.22% | 15.35B | |
| +4.32% | 12.42B | |
| -2.34% | 11.88B | |
| +32.69% | 12.19B |
NOVO INTEGRATED SCIENCES, INC. 
